Literature DB >> 23536099

The Arab Spring: confronting the challenge of non-communicable disease.

Bayard Roberts1, Preeti Patel, Maysoon Dahab, Martin McKee.   

Abstract

This Commentary considers the health system and policy challenges of addressing non-communicable diseases (NCDs) in Egypt, Libya, and Tunisia, countries in the process of re-framing state policies and institutions, including in the health sector. Against this backdrop, a neglected issue of the rapidly rising burden of NCDs threatens both health and economic development. Tackling this worrisome rise in NCDs has been impeded by inadequate policies. Weak health systems, little attention to determinants of health, and limited access to affordable health care complicate effective responses to NCDs, especially in a fragile transitional phase. There remains an opportunity to confront the neglected challenge of NCDs by substantially strengthening policies and scaling up comprehensive health systems to more effectively address the causes and treatment of NCDs, including mental health, ultimately to improve population health overall.

Mesh:

Year:  2013        PMID: 23536099     DOI: 10.1057/jphp.2013.14

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  2 in total

1.  Viewpoint: methanol poisoning outbreak in Libya: a need for policy reforms.

Authors:  Ziyad Ben Taleb; Raed Bahelah
Journal:  J Public Health Policy       Date:  2014-05-15       Impact factor: 2.222

2.  Context-led capacity building in time of crisis: fostering non-communicable diseases (NCD) research skills in the Mediterranean Middle East and North Africa.

Authors:  Peter Phillimore; Abla M Sibai; Anthony Rizk; Wasim Maziak; Belgin Unal; Niveen Abu Rmeileh; Habiba Ben Romdhane; Fouad M Fouad; Yousef Khader; Kathleen Bennett; Shahaduz Zaman; Awad Mataria; Rula Ghandour; Bülent Kılıç; Nadia Ben Mansour; Ibtihal Fadhil; Martin O'Flaherty; Simon Capewell; Julia A Critchley
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.